About the Patented Medicine Prices Review Board

Service Standards

Service Standards publicly state the level of performance that citizens can reasonably expect to encounter from the PMPRB under normal circumstances.

Timeliness service standards for high-volume regulatory authorizations clarify expectations and increase predictability in the federal regulatory system. They benefit the many Canadians, particularly businesses, who must seek permission from the federal government to either conduct a regulated activity or be exempt from it.

Review of Patented Drug Products

• Service Standard for the scientific review of new patented drug products
• Service Standard for the price review of new patented drug products
• Service Standard for the price review of existing patented drug products

For more information

• Government-Wide Forward Regulatory Plans
• The Cabinet Directive on Regulatory Management
• The Red Tape Reduction Action Plan
• The Canada-United States Regulatory Cooperation Council

To learn about upcoming or ongoing consultations on proposed federal regulations, visit the Canada Gazette and Consulting with Canadians websites.